Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
Valeria RiccieriGreta PellegrinoEdoardo CipollettaDilia GiuggioliGianluigi BajocchiSilvia Bellando-RandoneLorenzo DagnaGiovanni ZanframundoRosario FotiFabio CacciapagliaGiovanna CuomoAlarico ArianiEdoardo RosatoGemma LepriFrancesco GirelliElisabetta ZanattaSilvia Laura BoselloIlaria CavazzanaFrancesca IngegnoliMaria De SantisGiuseppe MurdacaGiuseppina AbignanoNicoletta RomeoAlessandra Della RossaMaurizio CaminitiAnnamaria IulianoGiovanni CianoLorenzo BerettaGianluca BagnatoEnnio LubranoIlenia De AndresAlessandro GiolloMarta SaraccoCecilia AgnesFederica LumettiAmelia SpinellaLuca MagnaniCorrado CampochiaroGiacomo DE LucaVeronica CodulloElisa VisalliClaudio Di VicoAntonietta GiganteFrancesca SacconMaria Grazia LazzaroniFranco FranceschiniElena GeneraliGianna MennilloSimone BarsottiGiuseppa Pagano MarianoFrancesca CalabreseFederica FuriniLicia VultaggioSimone ParisiClara Lisa PeroniGerolamo BianchiFabrizio ContiFranco CozziSalvatore D'AngeloAndrea DoriaEnrico FusaroMarcello GovoniSerena GuiducciFlorenzo IannoneCarlo SalvaraniGian Domenico SebastianiClodoveo FerriMarco Matucci-CerinicRossella De AngelisPublished in: Journal of scleroderma and related disorders (2024)
Our data provide a picture on the Italian use of intravenous iloprost among systemic sclerosis patients and showed that it was usually employed in patients with a more aggressive spectrum of the disease. The disparity of intravenous iloprost treatment strategies in the different centers suggests the need of a rational therapeutical approach based on the clinical characteristics of different patients' subsets.